Author(s): Quintana FS
Abstract Share this page
Abstract Latin America has 23 countries ranging from Mexico, Central America, South America and the Caribbean, of these 19 countries are considered by the WHO as countries with high and very high risk, one of the similarities of our countries is poor access to services health and medicine, resulting from poor government investment in health as the amount used in this sector occupies only the best 3\% of the national budget and gross domestic product.Thus we know that the prevalence of hypertension varies widely from country to country and from city to city, presenting in Guatemala a prevalence of 40\%, while in other countries in the area ranges between 25 and 35\%, most complicated problem is that within the same country as the population this prevalence can vary greatly and have a different impact between populationsTherefore we know that the impact of cardiovascular disease within the range of non-communicable diseases occupies at least 30\% and of these about 70\% occupied countries of low and moderate income.In Latin American countries the rates of detection, diagnosis and control of hypertensive disease are not uy encouraging and have a common denominator, the educated, so it is not the same be diagnosed in the rural area or urban area, and of course this impacts the way it understands the disease.In the best Detection reached 60\% of the population (31-69\%), Treatment 31\% (14-48\%) and most frightening is that control rates on average were 12\% (7 - 18\%), and although we have no reliable statistics on the vast majority of countries, we could say that control rate should be less than 10\% in most cases.In recognition of the need to meet the challenge of improving the prevention and control of hypertension in the Americas and worldwide, the Centers for Disease Control and Prevention (CDC) and the Pan American Health Organization (PAHO), in collaboration with other stakeholders, have launched the Standardized Hypertension Treatment and Prevention (SHTP) Project. The SHTP Project's goal is to improve CVD prevention and management, using hypertension as the entry point, by developing and implementing an approach for standardizing the management of hypertension and strengthening health systems at the primary care level. The SHTP Project design aims to be feasible and flexible for worldwide applicability and can be adapted to improve control of other NCDs. Rationale for Strengthening Healthcare DeliveryAbout the Systems for Hypertension Control, Strengthening of health systems can help address challenges to hypertension control by addressing a number of barriers to effective and sustained hypertension like a Patient barriers, Provider Barriers and Health System Barries to medication availabilities and affordabilitiesTo effectively reduce the burden of hypertension within a care delivery system, it is essential to develop and implement a multipronged strategy based on strong political will. This strategy should create an environment where hypertension control is a priority and specific stakeholders, as well as leaders and champions, are identified with clearly defined roles and responsibilities. Involved parties should include patients, clinicians, pharmacists, and social service workers, as well as others to comprise a multidisciplinary team. Concrete targets and goals and an accountability mechanism should be established at all levels with a plan to conduct monitoring and evaluation. Financial resources, including funding sources and procurement mechanisms, should be considered and mobilized. Furthermore, a formative assessment should be conducted prior to implementation to inform the needs for the program's success.We are currently working on developing 20 x 20 LASH, 25 x 25 WHF and many others in order to achieve a reduction of the impact of cardiovascular disease and its risk factors, hypertension continues to grow and the prevalence is ever-increasing, Latin America occupies the highest prevalence rates and the worst controls, and if we do nothing about it, stop being silent murderer a chronicle of a death foretold.
This article was published in J Hypertens
and referenced in Journal of Pharmaceutical Care & Health Systems